Intellectus Partners LLC Sells 1,400 Shares of DocuSign, Inc. (NASDAQ:DOCU)

Intellectus Partners LLC lessened its position in DocuSign, Inc. (NASDAQ:DOCUFree Report) by 17.6% in the 4th quarter, Holdings Channel.com reports. The fund owned 6,577 shares of the company’s stock after selling 1,400 shares during the period. Intellectus Partners LLC’s holdings in DocuSign were worth $592,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in DOCU. Itau Unibanco Holding S.A. bought a new stake in shares of DocuSign in the 3rd quarter worth about $28,000. Kestra Investment Management LLC purchased a new position in DocuSign in the 4th quarter worth about $30,000. Brooklyn Investment Group purchased a new position in DocuSign in the 3rd quarter worth about $33,000. Modus Advisors LLC purchased a new position in DocuSign in the 4th quarter worth about $36,000. Finally, First Horizon Advisors Inc. increased its stake in DocuSign by 102.6% in the 4th quarter. First Horizon Advisors Inc. now owns 397 shares of the company’s stock worth $36,000 after buying an additional 201 shares during the period. Institutional investors own 77.64% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently commented on the stock. Hsbc Global Res raised shares of DocuSign to a “moderate sell” rating in a research note on Friday, December 6th. Wells Fargo & Company raised their price target on shares of DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a research note on Friday, December 6th. HSBC reaffirmed a “reduce” rating on shares of DocuSign in a research note on Friday, December 6th. Robert W. Baird raised their price target on shares of DocuSign from $59.00 to $100.00 and gave the stock a “neutral” rating in a research note on Friday, December 6th. Finally, Piper Sandler raised their target price on shares of DocuSign from $60.00 to $90.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $92.45.

Get Our Latest Report on DOCU

DocuSign Stock Up 0.1 %

Shares of DocuSign stock opened at $79.83 on Friday. The firm’s 50 day moving average price is $89.05 and its 200-day moving average price is $78.60. DocuSign, Inc. has a 52-week low of $48.70 and a 52-week high of $107.86. The company has a market cap of $16.13 billion, a P/E ratio of 16.46, a PEG ratio of 6.94 and a beta of 1.02.

Insider Transactions at DocuSign

In other news, CEO Allan C. Thygesen sold 40,000 shares of DocuSign stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $90.04, for a total value of $3,601,600.00. Following the transaction, the chief executive officer now owns 156,050 shares of the company’s stock, valued at $14,050,742. The trade was a 20.40 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Teresa Briggs sold 534 shares of DocuSign stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $94.60, for a total transaction of $50,516.40. Following the completion of the transaction, the director now directly owns 7,736 shares in the company, valued at approximately $731,825.60. The trade was a 6.46 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 686,010 shares of company stock valued at $66,102,694 in the last 90 days. Insiders own 1.66% of the company’s stock.

About DocuSign

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Further Reading

Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCUFree Report).

Institutional Ownership by Quarter for DocuSign (NASDAQ:DOCU)

Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.